×

PetIQ, Inc. Announces Pricing of Initial Public Offering

EAGLE, Idaho, July 20, 2017 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) announced today the pricing of its initial public offering of 6,250,000 shares of the Company’s Class A common stock at a public offering price of $16.00 per share. All of the shares of Class A common stock are being offered by the Company. The shares are expected to begin trading on the Nasdaq Stock Market on July 21, 2017 under the ticker symbol “PETQ.” In addition, PetIQ has granted the underwriters a 30-day option to purchase from PetIQ up to an additional 937,500 shares of its Class A common stock at the initial public offering price, less the underwriting discount and commissions.

The closing of the offering is expected to occur on July 26, 2017, subject to the satisfaction of customary closing conditions.

Jefferies and William Blair are acting as book-running managers for the proposed offering. Oppenheimer & Co, Raymond James, and SunTrust Robinson Humphrey are acting as co-managers.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. A copy of the final prospectus relating to this offering, when available, may be obtained from any of the following sources: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, telephone: (877) 547-6340 or email: prospectus_department@jefferies.com; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: (800) 621-0687 or email: prospectus@williamblair.com; Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, telephone: (212) 667-8563, or email: EquityProspectus@opco.com; Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, telephone: (800) 248-8863, or email: prospectus@raymondjames.com; SunTrust Robinson Humphrey, Inc., 303 Peachtree Street, Atlanta, GA 30308, telephone: (800) 685-4786 or email: STRHdocs@SunTrust.com.

About PetIQ, Inc.

PetIQ is a pet medication and wellness company bringing a broad portfolio of veterinarian-recommended over-the-counter pet medications to a network of leading national retail stores across the mass, club, grocery, pharmacy, and e-commerce channels. PetIQ’s mission is to deliver pet owners a pipeline of innovative products that combine leading technology with affordability, choice and convenience.

Contacts Media Cory Ziskind ICR 646-277-1232 cory.ziskind@icrinc.com Investors Katie Turner ICR 646-277-1228 katie.turner@icrinc.com

Source:PetIQ, Inc.